Ferring Uro-Oncology U.S.

Delivering innovative therapies for unmet U.S. patient needs via our franchise research, capabilities & partnerships. Community Guidelines

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

That's a wrap on @BladderCancerUS's 2026 Think Tank. Addressing unmet needs in bladder cancer requires collaboration across the community. Through shared learning, thoughtful discussion, and a commitment to advancing research, we can help move the field forward for patients. #BCANTT26​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

We're proud to sponsor @BladderCancerUS' Bladder Cancer Think Tank, where collaboration has the potential to spark ideas and action to help move care forward. #BCANTT26​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

Real-world evidence is helping advance non-muscle invasive bladder cancer care by informing treatment decisions and supporting more individualized, evidence-based approaches.​
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

@BladderCancerUS' ‘New Faces of Bladder Cancer Survey’ shows progress in trial awareness, shared decision-making between patients and providers, and education access, while highlighting inequities that still demand action.​

Learn more: https://t.co/DhF1qasGWu ​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

The rising incidence of non-muscle invasive bladder cancer highlights the need for innovation in uro-oncology. Learn why we are driven to turn scientific advancement into meaningful impact for all people affected by this disease: https://t.co/Xf66CmC3Se ​

​This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

For adults with non-muscle invasive bladder cancer (NMIBC) who no longer respond to Bacillus Calmette-Guerin (BCG) therapy, timely, open conversations are key to choosing a treatment reflective of individual needs. ​
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

In this @UrologyTimes interview, Drs. Ravi Chauhan and Jonathan Henderson discuss why better recognition and reporting of carcinoma in situ (CIS) in non–muscle invasive bladder cancer (NMIBC) matters, and why collaboration between healthcare providers is key: https://t.co/vCQsKpjwZy ​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

This Men’s Health Week is a call to action—prioritizing early recognition and fostering proactive conversations about urologic symptoms and bladder cancer risk factors to drive earlier diagnosis. #MensHealthWeek​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

We are inspired by the resilience and determination of people living with bladder cancer. On #NCSD2026, we #CelebrateLife and honor the patients, caregivers and healthcare providers at the heart of it all.​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

Thanks to all who visited our booth and attended our product theater at #AUA26. We're inspired by the bright future of progress in uro-oncology. Watch our video for event highlights. ​
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

This #BCAM, we're proud to sponsor @BladderCancerUS' Walks to End Bladder Cancer to shine a light on the disease and drive meaningful change in care. See why our team walks: https://t.co/FHYZXYMld0

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

We're proud to support early-career investigators shaping the future of uro-oncology. That’s why we were thrilled to attend @UrologyCareFdn's #AUA26 Gala and Ferring-sponsored Research Honors Program and Reception.​
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

From meaningful HCP conversations on bladder cancer to a “Show Stopper” booth win, #AUA26 was a strong reminder of the work ahead: advancing research, care and support for patients. Proud to partner with @BladderCancerUS to help move this work forward. ​

​Thank you for joining us at the Reception:​

Dr. @MichaelAhdootMD, Dr. @AdityaBagrodia, Dr. Aaron Berger, Dr. @UroCancerMD, Dr. @jreswara, Dr. @FedGhali, Dr. @UroBiehn, @mmdeoudes, Dr. @MattMossanen, Dr. @KSMurrayUro, Dr. @VigneshPackiam, Dr. @AnneSchuckmanMD, Dr. @BogdanaSchmidt, Dr. @RaisBahrami, Dr. @RuchikaTalwarMD. ​​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

Today, we announced real-world case series data on re-induction, presented at #AUA26. Learn more here: https://t.co/SlHFBG0dOg
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

Tune in for a product theater at #AUA26 with Dr. Michael Williams and a patient with non-muscle invasive bladder cancer (NMIBC).​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

Watch as our Senior Director, Medical Affairs Uro-Oncology, Denise D'Andrea, shares her excitement for the American Urological Association (AUA) Annual Meeting. #AUA26. ​
​
This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

As we head into #BladderCancerAwarenessMonth, we want to shine a light on the spectrum of bladder cancer experiences captured in @BladderCancerUS' recent survey. See the progress that's been made and the gaps that persist: https://t.co/DhF1qateM2 ​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

We bring together great minds, cutting-edge science and fierce determination to drive excellence in all aspects of innovation. Learn about our efforts to create solutions for patients now and in the future: https://t.co/GElqRnGG3k​

This post is intended for healthcare professionals in the U.S. only.

[Ferring Uro-Oncology U.S. @FerringUSUroOnc]

The FDA approved a label update to accelerate thaw time for our therapy. Learn about this news and our commitment to evolve our therapies to address the real-world needs of patients and the healthcare providers who care for them: https://t.co/2i8IWygw3C
​
This post is intended for healthcare professionals in the U.S. only.